Concord, MA, United States of America

Gina Lacorcia

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Genzyme Corporation, Eberhard-Karls-Universitat Tubingen. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gina Lacorcia. Retrieved from https://idiyas.com/inventor/gina-lacorcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Concord, MA (US) (2018 - 2021)
  • Bridgewater, NJ (US) (2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Gina Lacorcia

Introduction

Gina Lacorcia is a prominent inventor based in Concord, MA (US). She has made significant contributions to the field of immunology, particularly through her work on monoclonal antibodies. With a total of three patents to her name, her innovations are paving the way for advancements in immunosuppressive therapies.

Latest Patents

Gina Lacorcia's latest patents include the development of an anti-αβTCR antibody. This invention relates to humanized monoclonal antibodies that comprise the CDRs of murine antibody BMA031, which bind to the apTCR.CD3 complex and possess improved biological properties. Another notable patent focuses on methods for enhancing immunosuppressive therapy through the multiple administration of αβTCR-binding polypeptides. This disclosure details improved methods for using a humanized binding polypeptide specific for the alpha beta T cell receptor (αβ-TCR). Additionally, she has developed novel methods using humanized monoclonal antibodies and/or fragments to reduce αβ T cells in subjects relative to γδ cells.

Career Highlights

Throughout her career, Gina has worked with notable organizations such as Genzyme Corporation and Eberhard Karls Universität Tübingen. Her experience in these institutions has contributed to her expertise in the field of immunology and antibody development.

Collaborations

Gina has collaborated with esteemed colleagues, including Daniel Snell and Andreas Menrad. These partnerships have further enriched her research and innovations in the field.

Conclusion

Gina Lacorcia's work exemplifies the impact of innovative thinking in the realm of immunology. Her patents and collaborations highlight her commitment to advancing medical science through her inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…